Phenox GmbH
14
5
7
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
Role: collaborator
Targeting Real World Usage In Stroke Treatment
Role: lead
IntraCranial Atherosclerosis Related Large-vessel Occlusion Treated With Urgent Stenting (ICARUS)
Role: collaborator
Coating to Optimize Aneurysm Treatment In The New Flow Diverter Generation
Role: lead
EnDovascular Therapy Plus Best Medical Treatment (BMT) Versus BMT Alone for MedIum VeSsel Occlusion sTroke
Role: collaborator
To Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms
Role: collaborator
To Evaluate the Safety and Efficacy of Intracranial Stent Assisted Endovascular Treatment of Intracranial Aneurysms
Role: collaborator
pCONus Treatment of Wide Neck Intracranial Aneurysms
Role: lead
Coated Mongolian Aneurysm Treatment Study 2
Role: lead
Coated Mongolian Aneurysm Treatment Study 1
Role: lead
Diversion-p64 Post Market Clinical Follow-Up Study to Assess Safety and Effectiveness of the p64 Flow Modulation Device
Role: lead
pCONUS2 Treatment of Wide Neck Intracranial Aneurysms 2
Role: lead
SITS (Safe Implementation of Treatments in Stroke) Open Artery by Thrombectomy in Acute Occlusive Stroke Study
Role: collaborator
Acute Recanalization of Thrombo-Embolic Ischemic Stroke With pREset (ARTESp)
Role: lead
All 14 trials loaded